Timothy J. Ley, MD, a leukemia researcher and hematologist at Washington University School of Medicine in St. Louis, has received a seven-year, $6.4 million Outstanding Investigator Award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
The funding will allow him to continue research aimed at understanding the mutations that initiate acute myeloid leukemia (AML) and how they might be targeted with new approaches.
This is the first year the NCI has given Outstanding Investigator Awards, which go to scientists with “outstanding records of productivity” to pursue cancer research with unusual potential, according to the NCI.
“The NCI Outstanding Investigator Award addresses a problem that many cancer researchers experience: finding a balance between focusing on their science while ensuring that they will have funds to continue their research in the future,” said Dinah Singer, PhD, director of the NCI’s Division of Cancer Biology. “With seven years of uninterrupted funding, NCI is providing investigators the opportunity to fully develop exceptional and ambitious cancer research programs.”